- King of Prussia, United States
- Lead
Leads analytical strategy for late-phase small molecule products, owning comparability studies, characterisation strategies and post-approval change submissions. Partners across R&D, manufacturing sites and regulatory in a matrix, embedding method knowledge into tech transfers and defending strategies during health authority inspections.
PAT